CLINICAL AND ECONOMIC ANALYSIS OF USING OF LONG ACTION ERYTHROPOES STIMULATED AGENTS FOR THE TREATMENT OF ANEMIA CKD V HD PATIENTS
The article describes the ways to cost optimization of anemia treatment CKD - HD patients. Aims. dinical and economic analysis treatment of Anemia CKD VHD PTS with using long action Erythropoiesis Stimulating Agents (ESA). Methods. We calculated the true cost of anemia therapy with darbepoetin...
Main Authors: | M. Kolesnyk, N. Bezdetko, V. Novakivskyy |
---|---|
Format: | Article |
Language: | English |
Published: |
State Institution «Institute of Nephrology NAMS of Ukraine"
2015-08-01
|
Series: | Український Журнал Нефрології та Діалізу |
Subjects: | |
Online Access: | https://ukrjnd.com.ua/index.php/journal/article/view/165 |
Similar Items
-
USING OF LONG ACTION ERYTHROPOES STIMULATED AGENTS FOR TREATMENT OF ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASES V D ST
by: M. Kolesnyk, et al.
Published: (2014-11-01) -
Influence of Dialysis Modality on the Treatment of Anemia in Patients with End-Stage Kidney Disease
by: Hamzagic Nedim, et al.
Published: (2020-09-01) -
Darbepoetin Use for the Treatment of Anemia in Hemodialysis Patients in Saudi Arabia
by: Shaheen Faissal, et al.
Published: (2006-01-01) -
LONG-ACTING ERYTHROPOETIN EFFICACY IN THE TREATMENT OF NEPHROGENIC ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT A PREDIALYSIS STAGE
by: Yu S Milovanov, et al.
Published: (2012-06-01) -
Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial
by: Shubhadeep D. Sinha, et al.
Published: (2019-03-01)